Patents Examined by Cynthia Wilder
  • Patent number: 7462709
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: December 9, 2008
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Patent number: 7455995
    Abstract: Overexpression of the gene, BAALC, in biological samples from a patient is prognostic for tumor aggressiveness and unfavorable patient outcome. The present invention provides polynucleotide primers and probes for assaying for overexpression of BAALC transcripts. Kits containing the primers and probes are also provided. Also provided are antibodies for assaying for overexpression of BAALC proteins as well as peptide immunogens for producing the anti-BAALC antibodies. The present invention also provides methods for characterizing acute myelogenous leukemia, chronic myelogenous leukemia and prostate cancer in a patient, base on detection of BAALC overexpression.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: November 25, 2008
    Assignee: The Ohio State University Research Foundation
    Inventors: Stephan Markus Tanner, Albert de la Chapelle
  • Patent number: 7455975
    Abstract: An electrochemical detection system which specifically detects selected nucleic acid segments is described. The system utilizes biological probes such as nucleic acid or peptide nucleic acid probes which are complementary to and specifically hybridize with selected nucleic acid segments in order to generate a measurable current when an amperometric potential is applied. The electrochemical signal can be quantified.
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: November 25, 2008
    Assignee: ESA Biosciences, Inc.
    Inventors: Robert W. Henkens, John P. O'Daly, Marek Wojciechowski, Honghua Zhang, Najih Naser, R. Michael Roe, Thomas N. Stewart, Deborah M. Thompson, Rebecca Sundseth, Steven E. Wegner
  • Patent number: 7442782
    Abstract: The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: October 28, 2008
    Assignee: Regents of the University of Minnesota
    Inventors: Laura P. W. Ranum, John W. Day, Christina Liquori
  • Patent number: 7435561
    Abstract: This disclosure provides for methods and reagents for rapid multiplex RPA reactions and improved methods for detection of multiplex RPA reaction products. In addition, the disclosure provides new methods for eliminating carryover contamination between RPA processes.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: October 14, 2008
    Assignee: ASM Scientific, Inc.
    Inventors: Olaf Piepenburg, Colin H. Williams, Niall A. Armes
  • Patent number: 7432084
    Abstract: In one aspect the present invention provides methods of synthesizing a preparation of nucleic acid molecules, the methods comprising the steps of: (a) utilizing an RNA template to enzymatically synthesize a first DNA molecule that is complementary to at least 50 contiguous bases of the RNA template; (b) utilizing the first DNA molecule as a template to enzymatically synthesize a second DNA molecule, thereby forming a double-stranded DNA molecule wherein the first DNA molecule is hybridized to the second DNA molecule; (c) utilizing the first or second DNA molecule of the double-stranded DNA molecule as a template to enzymatically synthesize a first RNA molecule that is complementary to either the first DNA molecule or to the second DNA molecule; and (d) utilizing the first RNA molecule as a template to enzymatically synthesize a third DNA molecule that is complementary to the first RNA molecule.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: October 7, 2008
    Assignee: Rosetta Inpharmatics LLC
    Inventors: Daniel D. Shoemaker, Christopher D. Armour, Philip W. Garrett-Engele
  • Patent number: 7423024
    Abstract: Disclosed are methods of inhibiting autoreactive immune cell proliferation in a mammal, involving administering to the mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or an immune cell anti-proliferative fragment or analog thereof.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: September 9, 2008
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventor: Robert A. Murgita
  • Patent number: 7419818
    Abstract: The present invention provides an organic conductor comprising a deoxyribonucleic acid (DNA) and an electric charge-donating material bonded to the deoxyribonucleic acid, and an organic conductor comprising at least two DNAs; and an electric charge-transfer substance bonding to each base of the two DNAs.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: September 2, 2008
    Assignee: Fuji Xerox Co., Ltd
    Inventors: Taishi Shigematsu, Kei Shimotani, Chikara Manabe, Hiroyuki Watanabe, Masaaki Shimizu
  • Patent number: 7417133
    Abstract: The present invention provides a method for obtaining thermostable enzymes. The present invention also provides variants of DNA polymerase I from Thermus aquaticus. The present invention further provides methods of identifying mutant DNA polymerases having enhanced catalytic activity. The present invention also provides polynucleotides, expression systems, and host cells encoding the mutant DNA polymerases. Still further, the present invention provides a method to carry out reverse transcriptase-polymerase chain reaction (RT-PCR) and kits to facilitate the same.
    Type: Grant
    Filed: February 27, 2004
    Date of Patent: August 26, 2008
    Assignee: Institut Pasteur
    Inventors: Jean-Luc Jestin, Sophie Vichier-Guerre
  • Patent number: 7384770
    Abstract: A set of primer pairs for amplifying a nucleic acid of an acetic acid-producing bacteria, each primer containing an oligonucleotide selected from the ackA gene region of the acetic acid-producing bacteria. The primers are particularly suitable for amplifying the nucleic acid of acetic acid-producing bacteria present in gas and oil production operations.
    Type: Grant
    Filed: January 9, 2007
    Date of Patent: June 10, 2008
    Assignee: Gas Technology Institute
    Inventor: Xiangyang Zhu
  • Patent number: 7267956
    Abstract: Nucleic acid sequences for detecting the presence of nucleic acids, particularly mRNA, encoding human prostate-associated genetic markers encoding prostate-specific antigen (PSA), prostate specific membrane antigen (PSMA) or human kallikrein 2 (hK2) are disclosed. Preferred combinations of nucleic acid sequences amplifying and detecting the prostate-associated genetic markers RNA, used in methods that include amplification of the target sequences and detection of the amplified sequences are disclosed. Methods of detecting the presence of prostate-associated genetic marker nucleic acids, particularly mRNA, in a biological sample of non-prostate origin are disclosed.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 11, 2007
    Assignee: Gen-Probe Incorporated
    Inventors: Richard C. Harvey, Thomas J. Clark, Jr.
  • Patent number: 7250254
    Abstract: A method of detecting reciprocal gene translocations by employing multiple probe sets which span the breakpoint regions and encompass regions on both sides of each breakpoint of the translocation on each chromosome involved in the translocation. Probe sets and diagnostic kits for the method are also disclosed.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: July 31, 2007
    Assignee: Ventana Medical Systems, Inc
    Inventors: Jeanne Dietz-Band, Wang-Ting Hsieh, John F. Connaughton
  • Patent number: 7238794
    Abstract: The present invention provides an organic conductor comprising a deoxyribonucleic acid (DNA) and an electric charge-donating material bonded to the deoxyribonucleic acid, and an organic conductor comprising at least two DNAs; and an electric charge-transfer substance bonding to each base of the two DNAs.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: July 3, 2007
    Assignee: Fuji Xerox Co., Ltd.
    Inventors: Taishi Shigematsu, Kei Shimotani, Chikara Manabe, Hiroyuki Watanabe, Masaaki Shimizu
  • Patent number: 7235363
    Abstract: A method for the screening of ligands which bind to soluble ?2?-1 subtype polypeptides.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: June 26, 2007
    Assignee: Warner-Lambert Company
    Inventors: François Bertelli, Jason Peter Brown, Visaka Udeni Karalliadde Dissanayake, Nirmala Suman-Chauhan, Nicolas Steven Gee
  • Patent number: 7223538
    Abstract: An assay is provided for nucleic acids that can be post-synthetically labeled, wherein modified nucleoside triphosphates are used that are more efficiently and specifically incorporated during nucleic acid synthesis than labeled nucleoside triphosphates. In a preferred embodiment, nucleoside ?-thiotriphosphates are utilized. Maleimide or iodoacetamide conjugating moieties can be attached post-synthetically. The conjugating moieties may include a reporter group. Also disclosed are new methods for detecting single nucleotide polymorphism.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: May 29, 2007
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Charles K. Brush, Vineet Gupta
  • Patent number: 7216792
    Abstract: An article of manufacture including an organic structure and inorganic atoms bonded to specific locations on the organic structure.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: May 15, 2007
    Assignee: International Business Machines Corporation
    Inventors: Ravi F. Saraf, Hemantha K. Wickramesinghe
  • Patent number: 7214522
    Abstract: The present invention provides compositions comprising thermostable DNA polymerases derived from hyperthermophilic eubacteria. In particular, the present invention comprises thermostable DNA polymerases from the hyperthermophilic eubacterial species Thermoactinomyces vulgaris. The present invention also provides methods for utilizing naturally-occurring and non-naturally-occurring forms of T. vulgaris DNA polymerase in sequencing, reverse transcription, and amplification reactions.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: May 8, 2007
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Patent number: 7192745
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: March 20, 2007
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Patent number: 7183084
    Abstract: The present invention is directed to a method for the determination of a target nucleic acid using a special control nucleic acid, a method for the amplification of a partial sequence of said target nucleic acid using primers, a special control and a kit containing said control. The sequence of these control nucleic acids are at least in part parallel-complementary to the sequence of the target nucleic. These controls have similar properties as the target nucleic acid in hybridization and amplification methods, but can be well differentiated from the target nucleic acid by their different sequence.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: February 27, 2007
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Stephan Jaeger
  • Patent number: 7153653
    Abstract: The present invention provides a method for detecting a cellular proliferative disorder in a subject. The method includes contacting a nucleic acid-containing specimen from the subject with an agent that provides a determination of the methylation state of at least one gene or associated regulatory region of the gene and identifying aberrant methylation of regions of the gene or regulatory region, wherein aberrant methylation is identified as being different when compared to the same regions of the gene or associated regulatory region in a subject not having said cellular proliferative, thereby detecting a cellular proliferative disorder in the subject.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: December 26, 2006
    Assignee: The Johns Hopkins University School of Medicine
    Inventors: Michael G. Goggins, Takashi Ueki